Anaphylaxis Treatment Market is expected to reach US$ 4,787.66 million by 2028

PRESS RELEASE BY The Insight Partners 23 Jun 2021

Share this press on

Food Allergy Segment to Hold Largest Market Share by Allergy Type During 2021–2028


According to our new research study on “Anaphylaxis Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Medication Type, Route of Administration,  Allergy Type, and Distribution Channel,” the market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the anaphylaxis treatment market is mainly attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. However, poor accessibility to epinephrine auto-injectors in low-income countries hinders the market growth.


Based on allergy type, the anaphylaxis treatment market is segmented into food allergy, medications, insect stings, and others. The food allergy segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period. The increasing number of food allergy incidences is contributing to the market growth for this segment. For instance, according to the Food Allergy & Anaphylaxis Connection Team (FAACT), in America, food allergies affect as many as 32 million, including 26 million adults and 5.6 million children. They are approximately affecting 7.6% of children and 10.8% of adults in the United States.


Amneal Pharmaceuticals Inc; Bioprojet; Mylan N.V.; Adamis Pharmaceutical Corporation; Abbott; Pfizer Inc; Glaxosmithkline Plc; Merck And Co. Inc; Teva Pharmaceutical Industries Ltd; and ALK-ABELLó are among the leading companies operating in the anaphylaxis treatment market.


Anaphylaxis Treatment Market, by Region, 2020 (%)

Anaphylaxis Treatment Market, by Region, 2020 (%)

Anaphylaxis Treatment Market to Grow at a CAGR of 8.7% to reach US$ 4,787.66 million from 2021 to 2028

Download Free Sample

Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others), and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)


The report segments the anaphylaxis treatment market as follows:


By Medication Type

  • Epinephrine
  • Antihistamines
  • Steroids
  • Beta-Agonist
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Allergy Type

  • Food Allergy
  • Medications
  • Insect Stings
  • Others

By Distribution Channel

  • Food Hospital Pharmacies
  • Retail Sales
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Contact Us
Phone: +1-646-491-9876
Email Id:   
Download Free PDF Brochure